Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Reply to M. K. Bos et al

Jamie M Sperger1, Felix Y Feng1, Andrew J Armstrong1

  • 1Jamie M. Sperger, PhD, Carbone Cancer Center and Department of Medicine, University of Wisconsin, Madison, WI; Felix Y. Feng, MD, Helen Diller Family Comprehensive Cancer Center, Division of Hematology and Oncology, Department of Medicine, UCSF, Department of Radiation Oncology, Department of Urology, University of California San Francisco, San Francisco, CA; Andrew J. Armstrong, MD, Duke Cancer Institute Center for Prostate and Urologic Cancers, Duke University, Durham, NC; Shuang G. Zhao, MD, Carbone Cancer Center and Department of Medicine, University of Wisconsin, Madison, WI, Department of Human Oncology, University of Wisconsin, Madison, WI, William S. Middleton Memorial Veterans Hospital, Madison, WI; and Joshua M. Lang, MD, MS, Carbone Cancer Center and Department of Medicine, University of Wisconsin, Madison, WI, Department of Medicine, University of Wisconsin, Madison, WI.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|December 8, 2021
PubMed
Summary

No abstract available in PubMed .

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clinical and genomic predictors of sipuleucel-T outcomes in men with metastatic androgen pathway modulator resistant prostate cancer.

Research square·2026
Same author

Combining pathology artificial intelligence and genomic biomarkers to refine long-term postprostatectomy outcome prediction.

Journal of the National Cancer Institute·2026
Same author

Reply to: PCWG4: A Missed Opportunity to Make Bone-Protective Agents Mandatory for Patients With Bone Metastatic Castration-Resistant Prostate Cancer.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
Same author

Identifying and Addressing Barriers to Live Primary Prostate Cancer Cell Research in Veterans.

Cancer research communications·2026
Same author

Precision Diagnostics in Prostate Cancer Treatment (PREDICT): A Phase II Multiarm Biomarker-Based Study (Alliance A032102).

JCO oncology advances·2026
Same author

Genetic ancestry-concordant ceramide metabolism and response to androgen receptor pathway inhibition in metastatic castration-resistant prostate cancer.

Cancer·2026